Marly Didizian > Linklaters LLP > London, England > Lawyer Profile
Linklaters LLP Offices

ONE SILK STREET
LONDON
EC2Y 8HQ
England
- Firm Profile
- Go to...
Marly Didizian

Work Department
TMT Partner and Global Life Sciences and Healthcare Sector co-head, London
Position
Marly specialises in all types of global sourcing, supply chain and technology arrangements. She has particular expertise in complex business carve-outs and works across sectors including healthcare, consumer, financial sponsors, media, telecoms, financial services and data-driven businesses. She is also the global co-head of the firm’s Healthcare and Life Sciences sector.
Marly supports clients throughout the full lifecycle of their most important transformations and projects, from initial structuring and procurement to contentious and non-contentious renegotiations and terminations. Her deals often involve cutting-edge uses of technology, data and supply chain, often within complex regulatory frameworks.
She is also experienced in media and broadcasting transactions and related regulation, having been seconded to both the BBC and Ofcom.
Marly is ranked in MergerLinks’ top 5 leading female M&A lawyers in EMEA specialising in commercial carve-outs, and was voted one of the Hot 100 Lawyers by The Lawyer for her sourcing work.
Career
2004 to date Partner, Linklaters London
2001 – 2004 Managing Associate, Linklaters London
1997 – 2001 Associate, Linklaters London
1994 – 1996 Trainee, Linklaters London
Languages
Marly speaks French, Armenian and Arabic
Education
1992 – 1993 College of Law, London, Law Society Finals |
1989 – 1992 University of Cambridge, Robinson College, B.A. in Law (Upper Second)
Personal
Marly is committed to promoting inclusion and authenticity in the workplace and is a mentor to a number of talented professionals, both within the firm and at clients. She is also regularly invited to speak on diversity, including at the Economic Forum for Female Executives, and at the University of Law. She runs training programmes within the firm and with clients about bringing your authentic self to work.
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Hall of Fame)Praised for its ability to provide creative solutions tailored to bespoke situations, Linklaters LLP assists a litany of major pharmaceutical, biotech, digital health and medical device companies with work including transactions, patent and trade mark litigations and licensing disputes. Marly Didizian, described as ‘first choice for the tricky stuff’, co-heads the team and is noted on the market for her ability to handle high-profile pharma mergers and carve-outs. Fellow co-head Aisling Zarraga is equipped to handle matters spanning M&A, joint ventures and corporate governance advisory work. IP expert Yohan Liyanage assists clients with IP transactions and patent litigation. Trade mark and patent disputes are staples of Ian Karet‘s far-reaching practice. Katie Coltart has a proven track record in coordinating cross-border patent litigation.
London > Corporate and commercial > Commercial contracts
(Hall of Fame)Praised for its ‘exceptional‘ technical knowledge, Linklaters LLP is well versed in assisting customers and suppliers and advising on all stages of strategic projects, from inception to completion. The group often advises on commercial partnerships, and has a strong team of veteran commercial lawyers who ‘bring the level of experience that is needed’. At the helm is Marly Didizian, who often deals with supply chain contracts and whose clients include large technology companies; she has also been at the forefront of the group’s work on collaboration agreements in the life sciences and consumer sectors. Greg Palmer and Rich Jones, who were both promoted to partner in May 2023, are also key team members. Georgina Kon is a key contact for the group’s TMT matters.
Lawyer Rankings
- Hall of Fame London > Corporate and commercial > Commercial contracts
- Hall of Fame London > Industry focus > Life sciences and healthcare
- Commercial contracts London > Corporate and commercial
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Bank lending: investment grade debt and syndicated loans
- Dispute resolution > Banking litigation: investment and retail
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- Finance > Debt capital markets
- Finance > Derivatives and structured products
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Employment > Employers
- Real estate > Environment
- Corporate and commercial > Equity capital markets: mid-large cap
- Risk advisory > ESG
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- TMT (technology, media and telecoms) > Fintech: regulatory
- Finance > Debt capital markets
- Finance > Debt capital markets
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Projects, energy and natural resources > Infrastructure: Project finance and development
- TMT (technology, media and telecoms) > IT and telecoms
- Finance > Debt capital markets
- Real estate > Commercial property: corporate occupiers
- Finance > Debt capital markets
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Projects, energy and natural resources > Mining and minerals
- Finance > Debt capital markets
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Projects, energy and natural resources > Power (including electricity and nuclear)
- Transport > Rail
- Investment fund formation and management > Real estate funds
- Projects, energy and natural resources > Renewables
- Finance > Securitisation
- Projects, energy and natural resources > Water
Firm Rankings
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Risk advisory > Corporate governance
- Corporate and commercial > Corporate tax
- Finance > High yield
- Industry focus > Life sciences and healthcare
- Projects, energy and natural resources > Oil and gas
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Investment fund formation and management > Private funds
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Public sector > Administrative and public law
- Real estate > Commercial property: development
- Real estate > Construction: non-contentious
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Dispute resolution > International arbitration
- Dispute resolution > Public international law
- Industry focus > Retail and consumer
- Finance > Trade finance
- Real estate > Commercial property: corporate occupiers
- Crime, fraud and licensing > Fraud: civil
- Investment fund formation and management > Fund finance
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Finance > Transport finance and leasing
- TMT (technology, media and telecoms) > Sport